Association between serum BDNF levels and maternal perinatal depression: A review: Special Section on 'Translational and Neuroscience Studies in Affective Disorders' Section Editor, Maria Nobile MD, PhD

Autor: G M, Mandolini, M, Lazzaretti, G, Delvecchio, C, Bressi, J C, Soares, P, Brambilla

Publikováno v: Journal of affective disorders. 261

A large amount of studies demonstrated reduced serum Brain-Derived Neurotrophic Factor (BDNF) levels in stress-related and depressive disorders. However, it is still unclear if a similar deficit in BDNF concentrations might also characterize maternal

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::9371ed54ce25837b13b5d9480750408c
https://pubmed.ncbi.nlm.nih.gov/31416610

P.036 The assertive brain: phosphocreatine plus creatine levels from the anterior cingulate correlates with self-directness in healthy adolescents

Autor: D. Madonna, L. Squarcina, G. Delvecchio, M. Nobile, M. Mauri, C. Bonivento, M. Garzitto, S. Piccin, M. Molteni, B. Tomasino, C. Bressi, F. Fabbro, J. Stanley a, P. Brambilla

Publikováno v: European Neuropsychopharmacology. 29:S46

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3856142cd0a1766853f67fa9e214aadd
https://doi.org/10.1016/j.euroneuro.2019.09.102

Exploration of the HDAC2 foot pocket: Synthesis and SAR of substituted N-(2-aminophenyl)benzamides

Autor: Ron de Jong, Shawn M. O’Connell, Robert Melkus, Andrew John Jennings, Marc Navre, Jerome C. Bressi, Anthony R. Gangloff, Yiqin Wu, Charles E. Grimshaw, Robert J. Skene

Publikováno v: Bioorganic & Medicinal Chemistry Letters. 20:3142-3145

A series of N-(2-amino-5-substituted phenyl)benzamides (3-21) were designed, synthesized and evaluated for their inhibition of HDAC2 and their cytotoxicity in HCT116 cancer cells. Multiple compounds from this series demonstrated time-dependent bindin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acc77bb996c8a35bb0284c71c769c99d
https://doi.org/10.1016/j.bmcl.2010.03.091

Adjuvant Systemic Therapies in Patients with Colorectal Cancer: An Audit on Clinical Practice in Italy

Autor: F. Recchia, P. Marchei, R. Trevisonne, C. Pizza, S. Chiadò Cutin, M. Tonato, S. Del Prete, G. Vietti Ramus, C. Oliva, T. Iannone, Mario Roselli, V. Bortolussi, F. Nigro Imperiale, S. Venuta, V. Angelini, S. Cascinu, C. Volta, M. Musi, V. Guardasole, R. Ferraldeschi, L. Isa, Stefano Cascinu, F. Cognetti, M.L. Evangelista, E. Biondi, M.P. Sirgiovanni, C. Modenesi, V. Gebbia, D. Santini, E. Greco, E. Ferrazzi, M. Betti, F. Verderame, C. Bumma, G. Cicero, G. Pieri, G. Nastasi, A. Pessi, L. Patoia, S. Palazzo, M. Belli, C. Di Fonzo, Giuseppe Colucci, S. Cigolari, G. Fornarini, F. Ferraù, G. Rosati, A. Nuzzo, G. Porcile, P. Sozzi, A. Mozzicafreddo, M. Chetrì, B. Massidda, G. Luporini, A. Lembo, R. Carroccio, F. Testore, Enzo Ballatori, V. Bon-ciarelli, G. Ausili Cefaro, P. Marchetti, P. Berniolo, G. Filippelli, Enrico Cortesi, Salvatore Palazzo, A. Prosperi, G. Citone, M. Cremonesi, A. Peta, G. Rimondi, Giorgio Mustacchi, Francesco Di Costanzo, F. Marrocolo, R. Laricchiuta, R. Maurizi Enrici, D. Perrone, G. P. Iannello, Fausto Roila, A. Lavarello, L. Manzione, V. Lacava, G. Solina, P. Manente, A. Cioffi, R. Ceccherini, V. Sidoti, V. Picece, E. Recaldin, V. Tinessa, P. Giordani, M. D'Aprile, O. Bertetto, M. D'Amico, M. Serlenga, E. Vigevani, M. Mazzoli, Giovanni Mantovani, P. Marsilio, P. Rizzo, V. Mascia, G. Tonini, G. Carteni, Alberto Sobrero, B. Daniele, L. Milesi, Benedetta Ruggeri, G. Margutti, M. Botturi, M. Nicodemo, V. Silingardi, C. Iacono, A. Comandone, G. Colucci, P. Alessandroni, E. Zarra, G. Beretta, G. Reguzzoni, M. Turaz-za, L. Tonda, A. Rossi, G. Troccoli, S. Mosconi, G. Catalano, S. Bretti, T. Prantera, M. Destefanis, A. Sobrero, G. Cruciani, V. Sciacca, M. Marzola, P. Malacarne, M. Mandalà, L. Montalbetti, G. Tuveri, A Ruggiero, A. Zaniboni, G. Cetto, S. Spada, S. Barni, Roberto Labianca, C. Caroti, M.T. Ionta, C. Bressi

Publikováno v: Tumori Journal. 91:472-476

Aims and Background Rarely are conclusions from clinical trials summarized in international consensus conferences and promptly transferred to patient care. The adjuvant therapy for colorectal cancer used in daily clinical practice in Italy is describ

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8d0a699e849d960b649a6a8bece6fa4
https://doi.org/10.1177/030089160509100605

A disubstituted NAD + analogue is a nanomolar inhibitor of trypanosomal glyceraldehyde-3-phosphate dehydrogenase

Autor: Jerome C. Bressi, Kevin J Kennedy, Michael H. Gelb

Publikováno v: Bioorganic & Medicinal Chemistry Letters. 11:95-98

N6-Naphthalenemethyl-2'-methoxybenzamido-beta-NAD+, a derivative of a low micromolar first-generation inhibitor of trypanosomal glyceraldehyde phosphate dehydrogenase (GAPDH), was synthesized, taking advantage of methodology for the selective phosphi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::043e3b31c96e3b2bc8f4565c3059bee6
https://doi.org/10.1016/s0960-894x(00)00608-9